Search Results

There are 60207 results for: content related to: Optimizing clozapine through clinical decision making

  1. Clozapine versus typical neuroleptic medication for schizophrenia

    Intervention Review

    The Cochrane Library

    Adib Essali, Nahla Al-Haj Haasan, Chunbo Li and John Rathbone

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD000059.pub2

  2. Clozapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Claudia Asenjo Lobos, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz and Stefan Leucht

    Published Online : 10 NOV 2010, DOI: 10.1002/14651858.CD006633.pub2

  3. Newer atypical antipsychotic medication versus clozapine for schizophrenia

    Intervention Review

    The Cochrane Library

    Arja Tuunainen and Kristian Wahlbeck

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD000966

  4. Medical management of patients on clozapine: A guide for internists

    Journal of Hospital Medicine

    Volume 10, Issue 8, August 2015, Pages: 537–543, Wynne Lundblad, Pierre N. Azzam, Priya Gopalan, Clinton A. Ross and PharmD

    Version of Record online : 23 MAR 2015, DOI: 10.1002/jhm.2345

  5. Treatment-Resistant Schizophrenia

    Schizophrenia, Second Edition

    T.R.E. Barnes, P. Buckley, S.C. Schulz, Pages: 489–516, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470987353.ch26

  6. Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period

    Bipolar Disorders

    Volume 17, Issue 4, June 2015, Pages: 415–423, Chi-Shin Wu, Sheng-Chang Wang and Shi-Kai Liu

    Version of Record online : 8 OCT 2014, DOI: 10.1111/bdi.12261

  7. Factors affecting interindividual differences in clozapine response: a review and case report

    Human Psychopharmacology: Clinical and Experimental

    Volume 26, Issue 3, April 2011, Pages: 177–187, Francesco Saverio Bersani, Enrico Capra, Amedeo Minichino, Rossella Pannese, Nicoletta Girardi, Isabella Marini, Roberto Delle Chiaie and Massimo Biondi

    Version of Record online : 31 MAR 2011, DOI: 10.1002/hup.1191

  8. Clozapine for treatment-resistant bipolar disorder: a systematic review

    Bipolar Disorders

    Volume 17, Issue 3, May 2015, Pages: 235–247, Xian-Bin Li, Yi-Lang Tang, Chuan-Yue Wang and Jose de Leon

    Version of Record online : 27 OCT 2014, DOI: 10.1111/bdi.12272

  9. Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample

    Acta Psychiatrica Scandinavica

    Volume 130, Issue 6, December 2014, Pages: 487–497, H. Verdoux and E. Pambrun

    Version of Record online : 9 OCT 2014, DOI: 10.1111/acps.12344

  10. Pharmacological actions of the atypical antipsychotic drug clozapine: A review

    Synapse

    Volume 24, Issue 4, December 1996, Pages: 349–394, Charles R. Ashby Jr. and Rex Y. Wang

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199612)24:4<349::AID-SYN5>3.0.CO;2-D

  11. Sulpiride augmentation for schizophrenia

    Intervention Review

    The Cochrane Library

    Jijun Wang, Ichiro M Omori, Mark Fenton and Bernardo GO Soares

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD008125.pub2

  12. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Marianna Boso and Corrado Barbui

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD006324.pub2

  13. Clozapine-induced myocarditis, a widely overlooked adverse reaction

    Acta Psychiatrica Scandinavica

    Volume 132, Issue 4, October 2015, Pages: 231–240, K. J. Ronaldson, P. B. Fitzgerald and J. J. McNeil

    Version of Record online : 11 APR 2015, DOI: 10.1111/acps.12416

  14. Olanzapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling and Stefan Leucht

    Published Online : 17 MAR 2010, DOI: 10.1002/14651858.CD006654.pub2

  15. The emergin role of clozapine in the treatment of movement disorders

    Movement Disorders

    Volume 12, Issue 4, July 1997, Pages: 483–496, Stewart A. Factor and Dr. Joseph H. Friedman

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870120403

  16. You have free access to this content
    Effects of clozapine on the δ- and κ-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes

    British Journal of Pharmacology

    Volume 123, Issue 3, February 1998, Pages: 421–426, Toru Kobayashi, Kazutaka Ikeda and Toshiro Kumanishi

    Version of Record online : 3 FEB 2009, DOI: 10.1038/sj.bjp.0701621

  17. Decomposition of clozapine n-oxide in the qualitative and quantitative analysis of clozapine and its metabolites

    Journal of Pharmaceutical Sciences

    Volume 83, Issue 10, October 1994, Pages: 1412–1417, G. Lin, G. McKay, J. W. Hubbard and K. K. Midha

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600831010

  18. The practical management of refractory schizophrenia – the Maudsley Treatment REview and Assessment Team service approach

    Acta Psychiatrica Scandinavica

    Volume 130, Issue 6, December 2014, Pages: 427–438, K. Beck, R. McCutcheon, M. A. P. Bloomfield, F. Gaughran, T. Reis Marques, J. MacCabe, S. Selvaraj, D. Taylor and O. D. Howes

    Version of Record online : 9 SEP 2014, DOI: 10.1111/acps.12327

  19. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research

    Fundamental & Clinical Pharmacology

    Volume 24, Issue 2, April 2010, Pages: 139–160, Olivier Blanc, Georges Brousse, Alexandre Meary, Marion Leboyer and Pierre-Michel Llorca

    Version of Record online : 21 AUG 2009, DOI: 10.1111/j.1472-8206.2009.00751.x

  20. Genetic association between TNF-α −308 G>A polymorphism and longitudinal weight change during clozapine treatment

    Human Psychopharmacology: Clinical and Experimental

    Volume 25, Issue 4, June 2010, Pages: 303–309, Ying-Chieh Wang, Ya-Mei Bai, Jen-Yeu Chen, Chao-Cheng Lin, I-Ching Lai and Ying-Jay Liou

    Version of Record online : 28 MAY 2010, DOI: 10.1002/hup.1122